An investigation on cervical cancer and human papillomavirus vaccine knowledge, and analysis of influencing factors for choosing domestic or imported 2vHPV vaccine among females in Shenzhen, China

• Үндсэн зохиолчид: Linxiang Chen (Зохиогч), Fangfang Lu (Зохиогч), Ziqi Wang (Зохиогч), Hanqing Chen (Зохиогч), Mianling Chen (Зохиогч), Chunmiao Peng (Зохиогч), Kangming Chen (Зохиогч), Cuili Chen (Зохиогч), Huawei Xiong (Зохиогч), Xu Xie (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

In 2020, the domestic (Chinese native) 2v human papillomavirus (HPV) vaccine was approved for use in females. At present, there are obvious differences in demand for different HPV vaccines. We aimed to investigate knowledge level of cervical cancer and HPV vaccine and its influencing factors among t...